Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL Efexor XL

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
  • Introduction of new pack/pack size
Updated on 08/11/2011 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 14/09/2011 and displayed until 08/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 05/01/2011 and displayed until 14/09/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 18/08/2010 and displayed until 05/01/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 22/04/2010 and displayed until 18/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Individual presentations superseded by joint PIL
Updated on 27/01/2009 and displayed until 22/04/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Addition of separate PILs covering individual presentations
  • Change due to user-testing of patient information
Updated on 22/05/2008 and displayed until 27/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/04/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/12/2006 and displayed until 26/04/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 22/06/2006 and displayed until 21/12/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to how the medicine works
  • Change to side-effects
  • Change to date of revision
Updated on 09/08/2005 and displayed until 22/06/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/08/2005 and displayed until 09/08/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 22/12/2003 and displayed until 05/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 19/05/2003 and displayed until 22/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 13/12/2002 and displayed until 19/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 03/04/2002 and displayed until 13/12/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  venlafaxine hydrochloride